Highfine Biotech Achieves Fruitful Results at CPHI North America 2025

5/23/2025

Suzhou Highfine Biotech concludes CPHI North America 2025 with remarkable success, pioneering future pharma collaborations.

Review of the grand exhibition

From May 20 to 22, 2025, the North American CPHI Pharmaceutical Event was successfully concluded at the Pennsylvania Convention Center in Philadelphia. Highfine Biotech brought its core innovative products and breakthrough technology solutions to Golden Booth 1206, attracting more than 500 professional visitors from more than 10 countries worldwide to stop and communicate. More than 20 preliminary cooperation intentions were reached on-site, and strategic cooperation agreements were signed with many international pharmaceutical companies, becoming the focus of the exhibition.

Highfine Biotech

Highlight Review

As the focus of the golden booth in the main channel, the Highfine Biotech booth focused on "innovation-driven, global empowerment" and concentrated on displaying multiple core products; from high-quality peptide synthesis reagents, molecular building blocks to CDMO full-chain services, multiple internationally certified technical solutions attracted more than 300 groups of global customers to stop and communicate, and received high attention from European and American pharmaceutical companies and R&D institutions.

Highfine Biotech

The journey begins again

From Suzhou to the world, Highfine Biotech has continued to practice its mission of "empowering global innovative pharmaceutical companies" based on 22 years of industry accumulation. This exhibition is not only a window to showcase technological strength, but also an important hub to connect the North American market. In the future, we will bring the upgraded CDMO platform and innovative product pipeline to more international stages, and look forward to working with you on the road to innovation in the biopharmaceutical industry!

About Highfine Biotech

With 22 years of dedicated expertise in drug discovery, we specialize in providing high-quality peptide synthesis reagents, building blocks, linkers, protein crosslinkers, and CDMO services to global innovative pharmaceutical companies.

Innovation Never Stops, Empowering the Globe
In May, our Philadelphia journey bore fruitful results.
In June, we await your presence in Shanghai.
Moving forward, we wield technology as our brush,
Together, painting a new horizon for medicine!

Related Products

We share our popular related products that you may be interested in here. If you have any questions, please get in touch with us; our specialists will answer you within 24 hours.

N-BOC-4-Hydroxypiperidine

CAS RN

109384-19-2

Appearance

White powder

Purity

99,90%

Learn More...

1-Chloroethyl (4-nitrophenyl) carbonate

CAS RN

101623-69-2

Appearance

Off white powder

Purity

99% HPLC

Learn More...

...

CAS RN

326495-23-2

Appearance

White to light yellow solid

Purity

≥98.0%

Learn More...

Fmoc-D-Arg(pbf)-OH

CAS RN

187618-60-6

Appearance

White to off white powder

Purity

≥98% HPLC

Learn More...

CONTACT US

Please fill out the form below and our sales team will be happy to assist you with a quote on peptide synthesis reagents.

Thank you! Your message has been sent.
Unable to send your message. Please fix errors then try again.
Contact

Search

Popular Products: TBTU, HBTU, HOBT, HOPO

Leave a message

Thank you for visiting us. Please leave a message and we will reply by email.

Contact